Cargando…
Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial
INTRODUCTION: The migraine-preventive drug propranolol is efficacious in reducing pain from temporomandibular disorder, suggesting potential modifying or mediating effects of comorbid migraine. METHODS: In this randomized controlled trial, myofascial temporomandibular disorder patients were treated...
Autores principales: | Tchivileva, Inna E, Ohrbach, Richard, Fillingim, Roger B, Lim, Pei Feng, Giosia, Massimiliano Di, Ribeiro-Dasilva, Margarete, Campbell, John H, Hadgraft, Holly, Willis, Janet, Arbes, Samuel J, Slade, Gary D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166404/ https://www.ncbi.nlm.nih.gov/pubmed/33560875 http://dx.doi.org/10.1177/0333102421989268 |
Ejemplares similares
-
COMT Genotype and Efficacy of Propranolol for TMD
Pain: A Randomized Trial
por: Slade, G.D., et al.
Publicado: (2020) -
Effect of Treatment Expectation on Placebo Response and Analgesic Efficacy: A Secondary Aim in a Randomized Clinical Trial
por: Sanders, Anne E., et al.
Publicado: (2020) -
Clinical, psychological, and sensory characteristics associated with headache attributed to temporomandibular disorder in people with chronic myogenous temporomandibular disorder and primary headaches
por: Tchivileva, Inna E., et al.
Publicado: (2021) -
Association between INADL genetic variant and a subgroup with high risk for TMD in the OPPERA study
por: Smith, Shad B, et al.
Publicado: (2014) -
Evaluation of Plasma Calcitonin Gene-Related Peptide as a Biomarker for Painful Temporomandibular Disorder and Migraine
por: Tchivileva, Inna E, et al.
Publicado: (2023)